[ad_1]
Positive study results for Eisai-Biogen lifted the prospects for its medication and one from Eli Lilly—although regulators will have to weigh risks.
[ad_2]
Source link
Array
Newest Alzheimer's Drugs Take Big but Fraught Step Toward Approval
RELATED ARTICLES